Mrs
Ellie
Purnell

Patent Director

Manchester Office

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.

Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.

Specialisms

  • Agbio
  • Gene editing technologies
  • Immunobiology

Industries

  • Agrochemicals icon Agrochemicals
  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices

Services

  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


MA

(Cantab) Natural Sciences - Double First Class Honours

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction

Recognition

Senior Scholar and Honarary Senior Scholar of Gonville & Caius College, Cambridge

Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010

The Frank Smart Prize for Botany

Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010

The Keith Farewell Prize

Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)

Publications

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

AI solution to Levinthal's paradox

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

A look at the WIPO coronavirus tools

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

G3/19: An end to the saga…

View publication online

G3/19: A further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

G3/19: A Further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

A look at the WIPO coronavirus tools

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

How a platform technology patent list can expedite covid-19 vaccine research

View publication online

The Patent Landscape Behind COVID-19 Vaccines

View publication online

Conferences: 2021

January 7th 2021

iBioIC

Attended

Event details

Conferences: 2020

November 4th 2020

Bionow Oncology Conference 2020

Attended

Event details

CSR

Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.

She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).

In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.

Related News

EPO Enlarged Board of Appeal decision G4/19 - a European patent application can be refused by reason of the prohibition on double patenting

The European Patent Office today confirmed in Decision G4/19 of the Enlarged board of Appeal that a European patent application can be refused for ‘double patenting’.  Such a refusal can …

Read article

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.